Ceruletide suppresses endogenous dopamine release via vagal afferent system, studied by in vivo intracerebral dialysis
- 1 March 1989
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 483 (1) , 78-83
- https://doi.org/10.1016/0006-8993(89)90036-x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Modulation of Memory Processing by Cholecystokinin: Dependence on the Vagus NerveScience, 1987
- Effects of cholecystokinin peptides and neurotensin on dopamine release and metabolism in the rostral and caudal part of the nucleus accumbens using intracerebral dialysis in the anaesthetized ratNeurochemistry International, 1987
- Effect of systemically administered caerulein on dopamine metabolism in rat brainBrain Research, 1984
- The cholecystokinin analogue, caerulein, does not modulate dopamine release or dopamine-induced locomotor activity in the nucleus accumbens of ratNeuroscience Letters, 1984
- Caerulein, a cholecystokinin-related peptide, depresses somatic function via the vagal afferent systemLife Sciences, 1983
- The effect of vagotomy on the satiety effects of neuropeptides and naloxoneLife Sciences, 1982
- Abdominal Vagotomy Blocks the Satiety Effect of Cholecystokinin in the RatScience, 1981
- Cholecystokinin receptors: Presence and axonal flow in the rat vagus nerveLife Sciences, 1981
- Central depressant effects of caerulein and cholecystokinin octapeptide (CCK-8) differ from those of diazepam and haloperidolNeuropharmacology, 1981
- Evidence for coexistence of dopamine and CCK in meso-limbic neuronesNature, 1980